Legal Representation
Attorney
Aaron D. Hendelman
USPTO Deadlines
Application History
50 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Feb 13, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Feb 13, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Feb 13, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Jul 7, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jul 7, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jul 7, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Feb 3, 2022 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | Loading... |
Feb 3, 2022 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
Jul 23, 2021 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Jul 23, 2021 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Jul 23, 2021 | CNFR | W | SU - FINAL REFUSAL - WRITTEN | Loading... |
Jul 14, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jul 14, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jul 13, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
Jun 7, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Dec 7, 2020 | GSPS | O | NOTIFICATION OF SU - PRIORITY ACTION E-MAILED | Loading... |
Dec 7, 2020 | GSPR | O | SU - PRIORITY ACTION E-MAILED | Loading... |
Dec 7, 2020 | SPRA | W | SU - PRIORITY ACTION WRITTEN | Loading... |
Nov 17, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Nov 16, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 16, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
May 14, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
May 14, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
May 14, 2020 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Apr 27, 2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Apr 20, 2020 | IUAF | S | USE AMENDMENT FILED | Loading... |
Apr 20, 2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Oct 25, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 24, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Oct 21, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Oct 15, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Oct 15, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Oct 15, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Oct 15, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Oct 15, 2019 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Oct 15, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Oct 15, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Oct 15, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 15, 2019 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Oct 15, 2019 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Apr 19, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 17, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Apr 17, 2019 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Apr 17, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Oct 13, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Oct 11, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Oct 11, 2018 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Oct 11, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Apr 14, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Apr 12, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Detailed Classifications
Class 005
Biological preparations for the treatment of cancer using genetically engineered cells; pharmaceutical preparations for targeting tissues based on select tissue markers and ligands; pharmaceutical preparations for the purpose of binding ligands using receptors; pharmaceutical preparations for immunotherapy using genetically engineered cells
First Use Anywhere:
20200200
First Use in Commerce:
20200200
Classification
International Classes
005